test

Oleg Nodelman

@Ecor1 Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
VRDNViridian Therapeutics Inc
Recent Activity
New Position
1.53%
$44.564M
1.959M shares@ $22.75 avg price
MBXMbx Biosciences Inc
Recent Activity
New Position
1.05%
$30.548M
1.176M shares@ $25.99 avg price
IONSIonis Pharmaceuticals Inc
Recent Activity
New Position
0.69%
$20.03M
500,000 shares@ $40.06 avg price
RLAYRelay Therapeutics Inc
Recent Activity
New Position
0.61%
$17.7M
2.5M shares@ $7.08 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
New Position
0.42%
$12.009M
862,068 shares@ $13.93 avg price
ETONEton Pharmaceuticals Inc
Recent Activity
New Position
0.17%
$4.764M
794,075 shares@ $6.0 avg price
BBIOBridgebio Pharma Inc
Recent Activity
New Position
0.15%
$4.333M
170,172 shares@ $25.46 avg price
AADIAadi Bioscience Inc
Recent Activity
New Position
0.14%
$3.801M
1.845M shares@ $2.06 avg price
HOOKHookipa Pharma Inc
Recent Activity
New Position
0.09%
$2.458M
571,727 shares@ $4.3 avg price
ALGSAligos Therapeutics Inc
Recent Activity
New Position
0.08%
$2.213M
255,573 shares@ $8.66 avg price